Target intelligence / Profile preview

Capicua transcriptional repressor pseudogene 1 (CICP1)

Target
CICP1
Molecular classification
Pseudogene, Other
01

Overview

Capicua transcriptional repressor pseudogene 1 (CICP1) is a genetic element classified as a pseudogene, meaning it shares sequence similarity with a functional gene (likely the capicua transcriptional repressor gene) but contains mutations such as premature stop codons, insertions, or frameshifts that disable its protein-coding potential[1][3][5]. Pseudogenes typically do not encode functional proteins nor participate directly in biological processes or diseases, although rare cases exist in which sequence information from pseudogenes can be incorporated into functional genes through gene conversion events, sometimes with deleterious consequences[2][3]. There is currently no evidence that CICP1 has any direct functional, therapeutic, or disease relevance, nor does it have known aliases, biomarkers, or drug interactions documented in major databases[1][3][5]. In summary, CICP1 is a non-functional pseudogene, not a molecular or therapeutic target. If you need more information about its parent gene or related capicua transcriptional repressors, further investigation into the functional CIR1 gene may be required[1][3].

02

Mechanism of action

None (no drugs target CICP1 or mechanism of action is documented)

03

Biological functions

Other
04

Disease associations

Other

Beyond the preview

Go deeper on Capicua transcriptional repressor pseudogene 1 (CICP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capicua transcriptional repressor pseudogene 1 (CICP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call